RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
FluoroPharma Medical Stock

FluoroPharma Medical Equity 2024

FluoroPharma Medical Equity

0 USD

Ticker

FPMI

ISIN

US3438701019

In 2024, FluoroPharma Medical's equity was 0 USD, a 0% increase from the 0 USD equity in the previous year.

FluoroPharma Medical Aktienanalyse

What does FluoroPharma Medical do?

FluoroPharma Medical Inc is an innovative company from the USA that specializes in molecular imaging. It was founded in 2003 and is based in Boston, Massachusetts. The company's goal is to improve the diagnosis and treatment of cardiovascular and cancer diseases. The business model of FluoroPharma Medical is based on the development of radioactive tracers that are used in conjunction with imaging techniques such as PET (Positron Emission Tomography). These tracers are typically administered in the form of radiopharmaceuticals and allow real-time tracking of metabolic processes in the body of patients. The information obtained is used by doctors to make diagnoses and optimize treatment. FluoroPharma Medical specializes in the development of tracers specifically for cardiovascular and cancer diseases. These include the tracer BFPET (up to 3 hours), which is used for the diagnosis of coronary heart disease, and the tracer CardioPET (up to 3 hours), which is used for the diagnosis of cardiovascular diseases. In addition, the company is working on other tracers that are intended for the diagnosis of various types of cancer, such as prostate cancer, breast cancer, and lung cancer. FluoroPharma Medical is divided into different divisions to better organize its activities. The Research and Development division is responsible for the development of new tracers and conducting clinical studies. The Production division is responsible for the manufacturing and distribution of radiopharmaceuticals. Marketing and distribution are handled by the Sales and Marketing division, which works closely with doctors and hospitals. The products of FluoroPharma Medical are currently still in the development phase and not commercially available. However, the company is working closely with various universities and medical facilities to test its tracers in clinical trials. The aim is to demonstrate the effectiveness and safety of the tracers and obtain approval from the FDA (Food and Drug Administration). FluoroPharma Medical has established itself as a pioneer in the field of molecular imaging and is committed to further improving the diagnosis and treatment of cardiovascular and cancer diseases. With its innovative tracers and focus on clinical practice, the company has the potential to significantly improve the medical care of patients in the future. FluoroPharma Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing FluoroPharma Medical's Equity

FluoroPharma Medical's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding FluoroPharma Medical's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating FluoroPharma Medical's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

FluoroPharma Medical's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in FluoroPharma Medical’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about FluoroPharma Medical stock

What is the equity of FluoroPharma Medical this year?

FluoroPharma Medical has equity of 0 USD this year.

What was the equity of FluoroPharma Medical compared to the previous year?

The equity of FluoroPharma Medical has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of FluoroPharma Medical?

A high equity is advantageous for investors of FluoroPharma Medical as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of FluoroPharma Medical?

A low equity can be a risk for investors of FluoroPharma Medical, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of FluoroPharma Medical affect the company?

An increase in equity of FluoroPharma Medical can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of FluoroPharma Medical affect the company?

A reduction in equity of FluoroPharma Medical can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of FluoroPharma Medical?

Some factors that can affect the equity of FluoroPharma Medical include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of FluoroPharma Medical so important for investors?

The equity of FluoroPharma Medical is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can FluoroPharma Medical take to change the equity?

To change equity, FluoroPharma Medical can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does FluoroPharma Medical pay?

Over the past 12 months, FluoroPharma Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, FluoroPharma Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of FluoroPharma Medical?

The current dividend yield of FluoroPharma Medical is .

When does FluoroPharma Medical pay dividends?

FluoroPharma Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of FluoroPharma Medical?

FluoroPharma Medical paid dividends every year for the past 0 years.

What is the dividend of FluoroPharma Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is FluoroPharma Medical located?

FluoroPharma Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von FluoroPharma Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of FluoroPharma Medical from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did FluoroPharma Medical pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of FluoroPharma Medical in the year 2023?

In the year 2023, FluoroPharma Medical distributed 0 USD as dividends.

In which currency does FluoroPharma Medical pay out the dividend?

The dividends of FluoroPharma Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von FluoroPharma Medical

Our stock analysis for FluoroPharma Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of FluoroPharma Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.